Home Cart Sign in  
Chemical Structure| 894187-61-2 Chemical Structure| 894187-61-2

Structure of STF-118804
CAS No.: 894187-61-2

Chemical Structure| 894187-61-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

STF-118804 is a highly specific and potent NAMPT inhibitor with IC50 values of 3-6 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of STF-118804

CAS No. :894187-61-2
Formula : C25H23N3O4S
M.W : 461.53
SMILES Code : O=C(NCC1=CC=CN=C1)C2=CC=C(C3=NC(CS(=O)(C4=CC=C(C)C=C4)=O)=C(C)O3)C=C2
MDL No. :MFCD14918065
InChI Key :DLFCEZOMHBPDGI-UHFFFAOYSA-N
Pubchem ID :20916937

Safety of STF-118804

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • NAMPT

In Vitro:

Cell Line
Concentration Treated Time Description References
SU86.86 100 nM 48-72 hours To evaluate the effect of STF-118804 on cell survival and growth, results showed that STF-118804 significantly reduced the viability of SU86.86 cells. Oncotarget. 2017 Jun 29;8(49):85054-85067.
PaTu8988t 25 nM 48-72 hours To evaluate the effect of STF-118804 on cell survival and growth, results showed that STF-118804 significantly reduced the viability of PaTu8988t cells. Oncotarget. 2017 Jun 29;8(49):85054-85067.
Panc-1 25 nM 48-72 hours To evaluate the effect of STF-118804 on cell survival and growth, results showed that STF-118804 significantly reduced the viability of Panc-1 cells. Oncotarget. 2017 Jun 29;8(49):85054-85067.
NB1691 neurosphere cells 0.01nM and above 10 days To evaluate the effect of STF-118804 on the self-renewal capacity of NB1691 neurosphere cells, results showed that STF-118804 at concentrations of 0.01nM and above significantly reduced neurosphere formation. Front Oncol. 2022 Jun 23;12:883318.
NB1691 cells 10nM and above 24 and 48 hours To evaluate the effect of STF-118804 on the viability of NB1691 cells, results showed that STF-118804 at concentrations of 10nM and above significantly reduced cell viability. Front Oncol. 2022 Jun 23;12:883318.
CRC119 cells 100 nM 68 hours Evaluate the effect of mycoplasma infection on resistance to NAMPT inhibitors Cell Metab. 2020 Mar 3;31(3):564-579.e7.
H1299 cells 1 μM 48 hours Screen for the effect of NAMPT inhibitors on cell viability Cell Metab. 2020 Mar 3;31(3):564-579.e7.
CRC119-Hyor cells 100 nM 72 hours Mycoplasma infection confers resistance to STF118804 Cell Metab. 2020 Mar 3;31(3):564-579.e7.
HCT116RFK866 28,500 nM 10 days Evaluate the antiproliferative effect of STF-118804 on HCT116RFK866 cells, showing an EC50 of 28,500 nM and a resistance index of 1,447. Oncotarget. 2018 Mar 27;9(23):16451-16461.
HCT116 19.7 nM 10 days Evaluate the antiproliferative effect of STF-118804 on HCT116 cells, showing an EC50 of 19.7 nM. Oncotarget. 2018 Mar 27;9(23):16451-16461.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Orthotopic pancreatic cancer model Intraperitoneal injection 25 mg/kg Twice daily for 20 days To evaluate the anti-tumor effect of STF-118804 in vivo, results showed that STF-118804 significantly reduced tumor size and weight. Oncotarget. 2017 Jun 29;8(49):85054-85067.
Nude mice NB1691 xenograft model Topical application 25mg/kg Once daily for 2 weeks To evaluate the effect of STF-118804 on tumor growth in the NB1691 xenograft model, results showed that STF-118804 significantly inhibited tumor growth. Front Oncol. 2022 Jun 23;12:883318.
Nu/J mice HCT116 xenograft tumor model Subcutaneous injection 15 mg/kg or 30 mg/kg Twice daily for 9-15 days Evaluate the effect of mycoplasma infection on the antitumor efficacy of STF118804 Cell Metab. 2020 Mar 3;31(3):564-579.e7.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.83mL

2.17mL

1.08mL

21.67mL

4.33mL

2.17mL

References

 

Historical Records

Categories